safingol and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
safingol has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Dietz, J; Grammatikos, G; Herrmann, E; Jakobi, K; Pfeilschifter, J; Röhrig, AM; Sarrazin, C; Thomas, D; Welsch, C; Zeuzem, S | 1 |
| Bon, D; Dietz, J; Dultz, G; Ferreiros, N; Grammatikos, G; Gute, P; Herrmann, E; Karakasiliotis, I; Knecht, G; Koch, A; Lutz, T; Mavromara, P; Pfeilschifter, J; Sarrazin, C; Zeuzem, S | 1 |
Other Studies
2 other study(ies) available for safingol and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
The role of serum sphingolipids as potential biomarkers of non-response to direct acting antiviral therapy in chronic hepatitis C virus infection.
Topics: Antiviral Agents; Biomarkers; Chromatography, Liquid; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Retrospective Studies; Sphingolipids; Sphingosine; Sustained Virologic Response; Tandem Mass Spectrometry | 2023 |
Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels.
Topics: Adult; Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Antiviral Agents; Biomarkers; Ceramides; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Male; Middle Aged; Sphingosine; Viral Load; Young Adult | 2016 |